Skip to main navigation
logo

Investor Navigation

  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Financials
    • SEC Filings
  • Governance
    • Documents & Charters
    • Board of Directors
    • Executive Team
    • Committee Composition
  • IR Resources
    • Investor FAQ
    • Contact IR
    • Email Alerts

Press Releases

14 Jan '2025
Context Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of CTIM-76
13 Jan '2025
Context Therapeutics Appoints Andy Pasternak as Chairman of the Board of Directors

Investor Tools

  • Print Page
  • RSS Feeds
  • Search

© 2025 Context Therapeutics Inc.     All rights reserved.